C4 Therapeutics, Inc.

CCCC · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.3B · 104 employees
107
SEC Filings
$4.38
Close 2026-06-01
104
Employees

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation, or TPD, science to create a new generation of small-molecule medicines that transform patients lives. Leveraging our proprietary TORPEDO platform, we efficiently design and optimize small molecule protein degraders that are highly active against their desired targets by harnessing the bodys natural process for destroying unwanted proteins. Our strategy is to...

Latest Stock Quote

CCCC 2026-06-01 $4.38 O:$4.36 H:$4.5981 L:$4.3 Vol:3.8M VWAP:$4.4375
origin leaf: 2626a2a4c028a16154f3e1c1cb54ef78b92a438f4c2bf79b669d4a57d68ce004

Next Earnings

Q2 FY2026 — expected 2026-09-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001628280-26-012000EDGAR94K words
2025-02-272024-12-310001628280-25-008433EDGAR—
2024-02-222023-12-310001628280-24-006144EDGAR—
2023-02-232022-12-310001628280-23-004711EDGAR—
2022-02-242021-12-310001564590-22-006499EDGAR—
2021-03-112020-12-310001564590-21-012531EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001628280-25-049854EDGAR61K words
2025-08-072025-06-300001628280-25-038587EDGAR—
2025-05-072025-03-310001628280-25-022866EDGAR—
2024-10-312024-09-300001628280-24-044411EDGAR—
2024-08-012024-06-300001628280-24-033882EDGAR—
2024-05-082024-03-310001628280-24-021368EDGAR—
2023-11-012023-09-300001628280-23-035793EDGAR—
2023-08-082023-06-300001628280-23-027941EDGAR—
2023-05-042023-03-310001628280-23-015459EDGAR—
2022-11-032022-09-300001628280-22-027985EDGAR—
2022-08-042022-06-300001628280-22-020886EDGAR—
2022-05-052022-03-310001564590-22-018046EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001628280-26-011971EDGAR2K words
2026-01-140001628280-26-002010EDGAR—
2025-11-060001628280-25-049850EDGAR—
2025-10-160001193125-25-241591EDGAR—
2025-10-160001628280-25-045157EDGAR—
2025-10-010001628280-25-043290EDGAR—
2025-09-220001628280-25-042245EDGAR—
2025-08-070001628280-25-038576EDGAR—
2025-06-180001628280-25-032155EDGAR—
2025-05-070001628280-25-022864EDGAR—

107 total filings indexed. 79 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001662579
TickerCCCC
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.c4therapeutics.com
Listed2020-10-02

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c63f8a79dcb5a663703f7586ed49f9d403a1da7b560f6e002229f169d1e02763
parent: 1d7b4cdb0621beb2ccc03eaff7765ca0178407fc65e2daa42817ee381c98cd85
content hash: 23b1e4a54b53e4e8084209bb29513d52d0e4958b1c2de196f630d0102ef14b45
signed: 2026-06-02T19:00:35.251Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf